These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
679 related items for PubMed ID: 27287686
1. Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study. Andersen LB, Dechend R, Karumanchi SA, Nielsen J, Joergensen JS, Jensen TK, Christesen HT. Am J Obstet Gynecol; 2016 Nov; 215(5):594.e1-594.e11. PubMed ID: 27287686 [Abstract] [Full Text] [Related]
2. Prediction of imminent preeclampsia at 35-37 weeks gestation. Ciobanu A, Wright A, Panaitescu A, Syngelaki A, Wright D, Nicolaides KH. Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886 [Abstract] [Full Text] [Related]
3. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia. Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA. Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883 [Abstract] [Full Text] [Related]
4. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers. Beck C, Allshouse A, Silver RM, Grobman WA, Simhan H, Haas D, Reddy UM, Blue NR. Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347 [Abstract] [Full Text] [Related]
6. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis. Chaemsaithong P, Gil MM, Chaiyasit N, Cuenca-Gomez D, Plasencia W, Rolle V, Poon LC. Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308 [Abstract] [Full Text] [Related]
7. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing. Espinoza J, Calsavara VF, Kilpatrick S, Rana S, Costantine MM, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Lemoine E, Thadhani R, Karumanchi SA. Am J Obstet Gynecol; 2024 Sep; 231(3):363.e1-363.e11. PubMed ID: 38825028 [Abstract] [Full Text] [Related]
9. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes. Coolman M, Timmermans S, de Groot CJ, Russcher H, Lindemans J, Hofman A, Geurts-Moespot AJ, Sweep FC, Jaddoe VV, Steegers EA. Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584 [Abstract] [Full Text] [Related]
10. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). Chaiworapongsa T, Romero R, Erez O, Tarca AL, Conde-Agudelo A, Chaemsaithong P, Kim CJ, Kim YM, Kim JS, Yoon BH, Hassan SS, Yeo L, Korzeniewski SJ. Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482 [Abstract] [Full Text] [Related]
11. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. Andersen LB, Dechend R, Jørgensen JS, Luef BM, Nielsen J, Barington T, Christesen HT. Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383 [Abstract] [Full Text] [Related]
12. Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geahchan C, Wenger JB, Thadhani R, Karumanchi SA, Rana S. Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880 [Abstract] [Full Text] [Related]
15. Circulating angiogenic proteins in trisomy 13. Bdolah Y, Palomaki GE, Yaron Y, Bdolah-Abram T, Goldman M, Levine RJ, Sachs BP, Haddow JE, Karumanchi SA. Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038 [Abstract] [Full Text] [Related]
16. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE. Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463 [Abstract] [Full Text] [Related]
17. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy. Verlohren S, Perschel FH, Thilaganathan B, Dröge LA, Henrich W, Busjahn A, Khalil A. Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601 [Abstract] [Full Text] [Related]
18. The additive role of angiogenic markers for women with confirmed preeclampsia. Suresh S, Patel E, Mueller A, Morgan J, Lewandowski WL, Verlohren S, von Dadelszen P, Magee LA, Rana S. Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699 [Abstract] [Full Text] [Related]
19. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM, Roland MC, Henriksen T, Michelsen TM. Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620 [Abstract] [Full Text] [Related]
20. First-trimester serum BAFF:sFlt-1 ratio as a candidate early biomarker of spontaneous abortion. Stohl HE, Yu N, Stohl W. Am J Reprod Immunol; 2021 Oct; 86(4):e13428. PubMed ID: 33837577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]